Cell Therapy for Immunomodulation in Kidney Transplantation
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study investigates treatment with recipient regulatory T cells and donor bone marrow
together with tocilizumab for immunomodulation in living donor kidney transplant recipients.